A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Omeros Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 53,100 shares of OMER stock, worth $632,421. This represents 0.0% of its overall portfolio holdings.

Number of Shares
53,100
Previous 62,600 15.18%
Holding current value
$632,421
Previous $254,000 17.32%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$3.54 - $5.47 $40,586 - $62,713
-11,465 Reduced 18.62%
50,112 $198,000
Q2 2024

Aug 14, 2024

BUY
$3.04 - $4.23 $73,023 - $101,608
24,021 Added 63.96%
61,577 $250,000
Q1 2024

May 15, 2024

SELL
$2.88 - $4.89 $43,652 - $74,117
-15,157 Reduced 28.75%
37,556 $129,000
Q4 2023

Feb 14, 2024

BUY
$1.08 - $3.63 $20,380 - $68,501
18,871 Added 55.76%
52,713 $172,000
Q3 2023

Nov 14, 2023

BUY
$2.81 - $5.69 $67,375 - $136,429
23,977 Added 243.05%
33,842 $98,000
Q2 2023

Aug 14, 2023

SELL
$4.45 - $7.57 $569,546 - $968,869
-127,988 Reduced 92.84%
9,865 $53,000
Q1 2023

May 15, 2023

BUY
$2.48 - $5.22 $119,888 - $252,345
48,342 Added 54.01%
137,853 $641,000
Q4 2022

Feb 14, 2023

BUY
$1.75 - $3.96 $58,815 - $133,091
33,609 Added 60.12%
89,511 $202,000
Q3 2022

Nov 14, 2022

SELL
$3.09 - $7.46 $1.03 Million - $2.48 Million
-332,480 Reduced 85.61%
55,902 $176,000
Q2 2022

Aug 15, 2022

BUY
$1.92 - $6.28 $271,806 - $889,034
141,566 Added 57.36%
388,382 $1.07 Million
Q1 2022

May 16, 2022

BUY
$5.07 - $7.2 $1.02 Million - $1.45 Million
201,769 Added 447.91%
246,816 $1.48 Million
Q3 2021

Nov 15, 2021

SELL
$13.4 - $16.3 $157,570 - $191,671
-11,759 Reduced 20.7%
45,047 $621,000
Q2 2021

Aug 16, 2021

SELL
$14.81 - $19.13 $283,344 - $365,995
-19,132 Reduced 25.19%
56,806 $843,000
Q1 2021

May 17, 2021

SELL
$14.52 - $23.53 $719,872 - $1.17 Million
-49,578 Reduced 39.5%
75,938 $1.35 Million
Q4 2020

Feb 16, 2021

SELL
$10.14 - $15.19 $911,920 - $1.37 Million
-89,933 Reduced 41.74%
125,516 $1.79 Million
Q3 2020

Nov 16, 2020

BUY
$9.57 - $21.32 $497,123 - $1.11 Million
51,946 Added 31.77%
215,449 $2.18 Million
Q2 2020

Aug 14, 2020

BUY
$12.21 - $16.99 $978,973 - $1.36 Million
80,178 Added 96.22%
163,503 $2.41 Million
Q1 2020

May 15, 2020

BUY
$9.03 - $19.72 $418,937 - $914,889
46,394 Added 125.62%
83,325 $1.11 Million
Q3 2019

Nov 14, 2019

SELL
$14.55 - $20.56 $284,903 - $402,585
-19,581 Reduced 34.65%
36,931 $603,000
Q2 2019

Aug 14, 2019

SELL
$15.0 - $19.62 $4.56 Million - $5.96 Million
-303,755 Reduced 84.31%
56,512 $887,000
Q4 2018

Feb 14, 2019

SELL
$10.72 - $16.73 $1.66 Million - $2.59 Million
-155,012 Reduced 30.08%
360,267 $4.01 Million
Q3 2018

Nov 13, 2018

BUY
$17.73 - $26.69 $8.09 Million - $12.2 Million
456,540 Added 777.23%
515,279 $0
Q1 2018

May 11, 2018

BUY
$9.0 - $20.16 $247,995 - $555,508
27,555 Added 88.36%
58,739 $656,000
Q4 2017

Feb 09, 2018

SELL
$13.26 - $22.86 $459,034 - $791,367
-34,618 Reduced 52.61%
31,184 $606,000
Q3 2017

Nov 09, 2017

BUY
$19.76 - $24.9 $1.3 Million - $1.64 Million
65,802
65,802 $1.42 Million

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $747M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.